Sep 07, 2022 / 01:10PM GMT
Timothy Ian Daley - Wells Fargo Securities, LLC, Research Division - Associate Analyst
All right. Great. So I am Tim Daley, Senior Analyst for the Life Science Tools, Diagnostics and Pharma Services sector here at Wells Fargo. I want to thank everybody for attending the 2022 Wells Fargo Healthcare Conference here in Boston. Honored today to have representatives from Bio-Techne. Joining me on the stage, we've got Jim Hippel, CFO; and then Will Geist, the President of the Protein Sciences division.
So we're going to go through some questions and answers. And then the last kind of 10 minutes or so, we will open it up for Q&A if anybody wants to join in. So great. Thanks for having.
James T. Hippel - Bio-Techne Corporation - Executive VP of Finance & CFO
Thanks for having us, Tim.
Questions and Answers:
Timothy Ian Daley - Wells Fargo Securities, LLC, Research Division - Associate AnalystAppreciate it. So yes, so given there's been a lot of movement in the macro environment over the last few weeks